Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS)
Clinical trial NCT04326283 · TERMINATED
Trial details
- NCT number
- NCT04326283
- Sponsor
- Genuv Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-02
- Primary completion
- 2023-04-28
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.